FDA must find happy medium between fast drug approval and assuring ...
492880
The public shouldn&#39;t have to wonder if the medicines they take are going to cure them or kill them. Recent suspicions that a number of painkillers carry potential health risks suggests the agency responsible
378410
Large drug companies may have to swallow some bitter medicine, but that could be healthy for shareholders.
337232
Two potentially new classes of anti-HIV drugs have the medical world excited. But progress on a vaccine is still slow  -  and drugs can't do everything
745761
The public should have reasonable expectations that medicines the Food and Drug Administration has approved for the market are, in fact, safe.
93812
The results from the new clinical trial could increase the chances that the Food and Drug Administration will approve the drug for that use.
438501
Here's what a newly approved drug looks like.
598332
The FDA will review its new cholesterol drug.
87010
New data are due out on a promising cholesterol drug. But there are doubters.
35159
Government drug-buying agency Pharmac wants drug companies to act more swiftly when concerns are raised over potential side-effects of their drugs, and to be responsible in promoting their products.
320147
Cancer drug shows exceptional promise as it moves toward FDA review.
20326
When a great launch of a good drug is not enough.
697522
If its latest drug isn't approved, the pharmaceutical could face trouble.
249661
About two-thirds of Food and Drug Administration scientists are less than fully confident in the agency's monitoring of the safety of prescription drugs now being sold.
116806
WASHINGTON - Americans should feel reasonably safe taking government-approved prescription drugs - with a few caveats - even after a popular arthritis medication was pulled from the market, medical experts say. But the problems with Vioxx raise questions about the Food and Drug Administration's safety review process and the length of time it took Merck to pull the drug, observers say...
35834
The Food and Drug Administration needs more staff, funding and authority over the drug industry to better track the safety of medicines after they reach the market, an Institute of Medicine report said Friday.
65911
WASHINGTON - About two-thirds of Food and Drug Administration scientists are less than fully confident in the agency&#39;s monitoring of the safety of prescription drugs now being sold, according to an FDA internal survey.
130395
Critics charge conflict of interest in a system where pharmaceutical giants fund the regulatory process. By Alexandra Marks | Staff writer of The Christian Science Monitor.